Anil K Dasyam1, Kishore Vipperla2, Adam Slivka2, Tang Gong3, Georgios I Papachristou4, David C Whitcomb2, Dhiraj Yadav2. 1. Division of Abdominal Imaging, Department of Radiology, University of Pittsburgh Medical Center, Pittsburgh, USA. Electronic address: dasyamak@upmc.edu. 2. Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, USA. 3. Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, USA. 4. Division of Gastroenterology, Hepatology & Nutrition, The Ohio State University Wexner Medical Center, Columbus, USA.
Abstract
OBJECTIVE: No standardized system is currently used to report the presence or severity of parenchymal and ductal features of chronic pancreatitis (CP) on CT scan. We report a modification to the previously proposed Cambridge classification to serve this purpose. METHODS: Contrast-enhanced CT scans of 158 well-phenotyped patients with CP enrolled in the North American Pancreatitis Studies (NAPS2) during 2000-2014 from the University of Pittsburgh were retrospectively reviewed by a subspecialty trained abdominal radiologist. Presence and severity (score scale 0-4) of pancreatic duct (PD) dilation, obstruction and contour irregularity, pancreatic calcifications, atrophy and extent of pancreatic involvement were recorded to grade the morphological severity of CP and stratify patients into distinct morphologic patterns. Findings were also correlated with clinical features. RESULTS: Pancreatic atrophy, calcifications, PD dilation and PD irregularity were observed in 80%, 68%, 65%, 58% cases, respectively. An obstructive stone or PD stricture was present in 63%, and 86% had diffuse pancreatic involvement. Using these features, CP was noted to be moderate or severe in 61%, and classified morphologically as obstructive with/without calcifications, calcific but non-obstructive and non-calcific/non-obstructive in 65%, 20%, 15%, respectively. Functional abnormalities but not the presence of pain generally correlated with imaging findings. CONCLUSION: A structured scoring system can provide qualitative and quantitative assessment of imaging findings in CP and an opportunity for adoption into clinical practice and research for initial evaluation and longitudinal follow-up. Our findings need validation in a prospective cohort before widespread adoption.
OBJECTIVE: No standardized system is currently used to report the presence or severity of parenchymal and ductal features of chronic pancreatitis (CP) on CT scan. We report a modification to the previously proposed Cambridge classification to serve this purpose. METHODS: Contrast-enhanced CT scans of 158 well-phenotyped patients with CP enrolled in the North American Pancreatitis Studies (NAPS2) during 2000-2014 from the University of Pittsburgh were retrospectively reviewed by a subspecialty trained abdominal radiologist. Presence and severity (score scale 0-4) of pancreatic duct (PD) dilation, obstruction and contour irregularity, pancreatic calcifications, atrophy and extent of pancreatic involvement were recorded to grade the morphological severity of CP and stratify patients into distinct morphologic patterns. Findings were also correlated with clinical features. RESULTS:Pancreatic atrophy, calcifications, PD dilation and PD irregularity were observed in 80%, 68%, 65%, 58% cases, respectively. An obstructive stone or PD stricture was present in 63%, and 86% had diffuse pancreatic involvement. Using these features, CP was noted to be moderate or severe in 61%, and classified morphologically as obstructive with/without calcifications, calcific but non-obstructive and non-calcific/non-obstructive in 65%, 20%, 15%, respectively. Functional abnormalities but not the presence of pain generally correlated with imaging findings. CONCLUSION: A structured scoring system can provide qualitative and quantitative assessment of imaging findings in CP and an opportunity for adoption into clinical practice and research for initial evaluation and longitudinal follow-up. Our findings need validation in a prospective cohort before widespread adoption.
Authors: L A Scuro; G Cavallini; L Benini; G Brocco; P Bovo; A Riela; M Togni; G Cataudella; C Bassi; P Pederzoli Journal: Int J Pancreatol Date: 1990-03
Authors: C Mel Wilcox; Dhiraj Yadav; Tian Ye; Timothy B Gardner; Andres Gelrud; Bimaljit S Sandhu; Michele D Lewis; Samer Al-Kaade; Gregory A Cote; Christopher E Forsmark; Nalini M Guda; Darwin L Conwell; Peter A Banks; Thiruvengadam Muniraj; Joseph Romagnuolo; Randall E Brand; Adam Slivka; Stuart Sherman; Stephen R Wisniewski; David C Whitcomb; Michelle A Anderson Journal: Clin Gastroenterol Hepatol Date: 2014-10-24 Impact factor: 11.382
Authors: David C Whitcomb; Dhiraj Yadav; Slivka Adam; Robert H Hawes; Randall E Brand; Michelle A Anderson; Mary E Money; Peter A Banks; Michele D Bishop; John Baillie; Stuart Sherman; James DiSario; Frank R Burton; Timothy B Gardner; Stephen T Amann; Andres Gelrud; Simon K Lo; Mark T DeMeo; William M Steinberg; Michael L Kochman; Babak Etemad; Christopher E Forsmark; Beth Elinoff; Julia B Greer; Michael O'Connell; Janette Lamb; M Michael Barmada Journal: Pancreatology Date: 2008-09-03 Impact factor: 3.996
Authors: Temel Tirkes; Zarine K Shah; Naoki Takahashi; Joseph R Grajo; Stephanie T Chang; Ashley M Wachsman; Kareem Mawad; Carlos A Farinas; Liang Li; Savitri N Appana; Darwin L Conwell; Dhiraj Yadav; Anil K Dasyam Journal: Abdom Radiol (NY) Date: 2020-05